NIT1 expression in NSCLC cells was significantly associated with poor differentiation of cancer cells, advanced TNM stages (III versus I+II), lymph node metastasis and poor clinical outcome of the patients ((60.70 ±5.48 vs 30.83 ± 4.88 months) (Table 1 and Figure 1) (p < 0.05). Here, NIT1 is linked to non-small cell lung carcinoma.